Toth Christopher A.
SEC CIK 1753950 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International | EVP, Group Pres, Kidney Care | 105.2K | — | — | 5 | 2023-06-01 | 2025-01-31 |
Most active insiders at BAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teaff James | Pres, CCS | — | — |
| 2 | Foster Julie | Pres, Front Line Care | — | — |
| 3 | Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| 4 | Carlisle Cynthia | EVP, CHRO | — | — |
| 5 | Ampofo William A. II | Dir | — | — |
| 6 | Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| 7 | Hider Andrew P. | Pres, CEO, Dir | — | — |
| 8 | Rosenbloom David S. | EVP, GC | — | — |
| 9 | Wilkes David S. | Dir | — | — |
| 10 | Wallace Steven P. | Pres, Adv. Surgery | — | — |
Toth Christopher A. made no open-market trades at BAX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-31 | BAX | Baxter International | Toth Christopher A. | EVP, Group Pres, Kidney Care | F - Tax | $32.56 | -25.4K | 105.2K | -19% | -$826.1K | |
| 2025-01-03 | 2024-12-31 | BAX | Baxter International | Toth Christopher A. | EVP, Group Pres, Kidney Care | F - Tax | $29.16 | -32.6K | 183.9K | -15% | -$950.9K | |
| 2024-06-05 | 2024-06-03 | BAX | Baxter International | Toth Christopher A. | EVP, Group Pres, Kidney Care | F - Tax | $34.08 | -15.2K | 213.3K | -7% | -$518.1K | |
| 2024-03-08 | 2024-03-06 | BAX | Baxter International | Toth Christopher A. | EVP, Group Pres, Kidney Care | A - Grant | $0.00 | +119.1K | 227.8K | +110% | $0 | |
| 2023-06-05 | 2023-06-01 | BAX | Baxter International | Toth Christopher A. | EVP, Group Pres, Kidney Care | A - Grant | $0.00 | +106.4K | 106.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations